|
2023 Journal Article Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES studyDeitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Jenkins, Aaron, Atreja, Nipun, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin, Sun, Xiaoxi and Lip, Gregory Y.H. (2023). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. European Journal of Internal Medicine, 108, 37-42. doi: 10.1016/j.ejim.2022.10.021 |
|
2022 Journal Article Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2)Deitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2). Journal of Thrombosis and Thrombolysis, 54 (4), 696-696. doi: 10.1007/s11239-022-02708-3 |
|
2022 Journal Article Payer formulary exclusions of apixaban: how patients respond and potential implicationsDeitelzweig, Steven, Terasawa, Emi, Kang, Amiee, Atreja, Nipun, Hines, Dionne M., Noman, Ahmed and Luo, Xuemei (2022). Payer formulary exclusions of apixaban: how patients respond and potential implications. Current Medical Research and Opinion, 38 (11), 1-6. doi: 10.1080/03007995.2022.2128189 |
|
2022 Journal Article Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19Deitelzweig, Steven, Zhu, Julia, Jiang, Jenny, Luo, Xuemei, Keshishian, Allison, Ferri, Mauricio, Rosenblatt, Lisa, Schuler, Patricia, Gutierrez, Cynthia and Dhamane, Amol D. (2022). Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. Current Medical Research and Opinion, 38 (11), 1891-1896. doi: 10.1080/03007995.2022.2112871 |
|
2022 Journal Article Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral AnticoagulantsLip, Gregory Y. H., Murphy, Richard R., Sahiar, Farhad, Ingall, Timothy J., Dhamane, Amol D., Ferri, Mauricio, Hlavacek, Patrick, Preib, Madison T., Keshishian, Allison, Russ, Cristina, Rosenblatt, Lisa, Yuce, Huseyin and Deitelzweig, Steven (2022). Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants. JAMA Network Open, 5 (8) e2229333, 1-12. doi: 10.1001/jamanetworkopen.2022.29333 |
|
2022 Journal Article Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databasesLip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Luo, Xuemei, Atreja, Nipun, Zhang, Yan, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. Journal of Thrombosis and Thrombolysis, 54 (1), 33-46. doi: 10.1007/s11239-022-02660-2 |
|
2022 Journal Article Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort studyDeitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study. Journal of Thrombosis and Thrombolysis, 53 (4), 766-776. doi: 10.1007/s11239-022-02644-2 |
|
2022 Journal Article Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairsDeitelzweig, Steve, Sah, Janvi, Kang, Amiee, Russ, Cristina, Preib, Madison, Dhamane, Amol D., Ratiu, Anna, Cato, Matthew, Alfred, Tamuno, Levi, Edi and Di Fusco, Manuela (2022). Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs. American Journal of Cardiology, 163, 43-49. doi: 10.1016/j.amjcard.2021.09.047 |
|
2021 Journal Article Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacyLip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. European Heart Journal - Cardiovascular Pharmacotherapy, 7 (5), 405-414. doi: 10.1093/ehjcvp/pvaa117 |
|
2021 Journal Article Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active CancerDeitelzweig, Steven, Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y.H. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC: CardioOncology, 3 (3), 411-424. doi: 10.1016/j.jaccao.2021.06.004 |
|
2021 Journal Article Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal BleedingLip, Gregory Y. H., Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding. JAMA Network Open, 4 (8) e2120064, 1-14. doi: 10.1001/jamanetworkopen.2021.20064 |
|
2021 Journal Article Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and MultimorbidityDeitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity. Advances in Therapy, 38 (6), 3166-3184. doi: 10.1007/s12325-021-01724-8 |
|
2021 Journal Article Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patientsDeitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. Therapeutic Advances in Gastroenterology, 14. doi: 10.1177/1756284821997352 |
|
2021 Journal Article Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulantsLip, G. Y. H. and Deitelzweig, S. B. (2021). Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants. Journal of Internal Medicine, 290 (1), 221-222. doi: 10.1111/joim.13296 |
|
2021 Journal Article Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysisDeitelzweig, Steven, Di Fusco, Manuela, Kang, Amiee, Savone, Mirko, Mokgokong, Ruth, Keshishian, Allison, Gutierrez, Cynthia and Cappelleri, Joseph C. (2021). Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. Current Medical Research and Opinion, 37 (6), 891-902. doi: 10.1080/03007995.2021.1897555 |
|
2020 Journal Article Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective studyHill, Jason B., Garcia, David, Crowther, Mark, Savage, Bryan, Peress, Shira, Chang, Kevin and Deitelzweig, Steven (2020). Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study. Blood Advances, 4 (21), 5373-5377. doi: 10.1182/bloodadvances.2020003083 |
|
2020 Journal Article Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USADeitelzweig, Steven B., Lovelace, Belinda, Christoph, Mary, Lingohr-Smith, Melissa, Lin, Jay and Fermann, Gregory J. (2020). Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA. Advances in Therapy, 37 (9), 3942-3953. doi: 10.1007/s12325-020-01440-9 |
|
2020 Journal Article Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES studyLip, G. Y.H., Keshishian, A. V., Kang, A. L., Dhamane, A. D., Luo, X., Li, X., Balachander, N., Rosenblatt, L., Mardekian, J., Pan, X., Di Fusco, M., Garcia Reeves, A. B., Yuce, H. and Deitelzweig, S. (2020). Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Journal of Internal Medicine, 289 (1) joim.13140, 42-52. doi: 10.1111/joim.13140 |
|
2020 Journal Article Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES StudyDeitelzweig, Steve, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Li, Xiaoyan, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Di Fusco, Manuela, Reeves, Alessandra B. Garcia, Yuce, Huseyin and Lip, Gregory Y. H. (2020). Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study. Journal of Clinical Medicine, 9 (6) 1633, 1-25. doi: 10.3390/jcm9061633 |
|
2020 Journal Article Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes MellitusLip, Gregory Y.H., Keshishian, Allison V., Kang, Amiee L., Li, Xiaoyan, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Nadkarni, Anagha, Pan, Xianying, Di Fusco, Manuela, Garcia Reeves, Alessandra B., Yuce, Huseyin and Deitelzweig, Steven B. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Mayo Clinic Proceedings, 95 (5), 929-943. doi: 10.1016/j.mayocp.2019.05.032 |
